Search
Search Funnelback University
- Refined by:
- Date: 2022
Your query has been expanded to news |u:www.enterprize.cam.ac.uk. Search for news |u:www.enterprise.cam.ac.uk instead.
31 -
50 of
183
search results for news |u:www.enterprise.cam.ac.uk or news |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Science and Technology Facilities Council (STFC) Knowledge Exchange…
https://www.enterprise.cam.ac.uk/grant/science-and-technology-facilities-council-stfc-knowledge-exchange-and-commercialisation-kec-fellowships/18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Knowledge Exchange and Commercialisation (KEC) Fellowships. The KEC Fellowship scheme is designed to facilitate the development of -
DIOSynVax: tackling COVID-19 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/diosynvax-tackling-covid-19/11 Apr 2022: Historically, the creation of an effective new vaccine has required years of work and hundreds of millions of pounds. -
CAM2 software for hearing aid fitting – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/cam2-software-for-hearing-aid-fitting/9 May 2022: CAM2 has been developed to provide a superior solution for the tailoring of wide-band hearing aid parameters using the audiogram alone, and is an essential new tool in the audiology -
New Head at Cambridge Enterprise Seed Funds | University of Cambridge
https://www.enterprise.cam.ac.uk/news/new-head-at-cambridge-enterprise-seed-funds/7 Apr 2022: Search. Search. New Head at Cambridge Enterprise Seed Funds. News. New Head at Cambridge Enterprise Seed Funds.. ... This news story was first published on Cambridge Enterprise's website on 06 April 2022. -
Research tools licensing – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/research-tools/19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process. -
Impact Insight: Xampla – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-xampla/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Xampla. Share:. Impact Insight video case study: Xampla. The first in our series of Impact Insight videos focuses on Xampla. It tells the exciting story of the research -
Impact Ideation Workshop: Global Sustainable Development Monday 28th…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/12/2022.11.23_AHSS-QA-Maryam-Tanwir_Web.pdf2 Dec 2022: But unfortunately the minute that there was a change in government, the new government cut off all funding and the project was in disarray. -
Impact Insight video case study: Xampla – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-xampla/15 Mar 2022: The first in our new series of Impact Insight videos focuses on Xampla. ... Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations emerging from the University, or an external -
KARPAS 25 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge. -
The Carbon Challenge: Daily Decarbonisation – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/carbon-challenge-2022/28 Jan 2022: For news on upcoming Carbon Challenge events and how to register, visit our Events pages. -
Creative Cambridge 2022 highlights – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/creative-cambridge-2022-highlights/18 Aug 2022: With themes of Content, Collections and Community, Creative Impact, and Creative Innovation, the day featured great speakers, inspirational panels, demos, pitches and of course conversation designed to spark new ideas and ... More on Creative Cambridge. -
KARPAS 417 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-417-human-myeloma-cell-line/9 May 2022: KARPAS 417 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge. -
Impact Insight video case study: Versed AI – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-versed-ai/15 Mar 2022: Impact Insight video case study: Versed AI. The second in our new series of Impact Insight videos focuses on Versed AI. ... Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations -
Realising the market potential of software – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/realising-the-market-potential-of-software/18 Jul 2022: Related news and case studies. Pause. Play. Review our answers to your most frequently asked questions. -
New grafting technique published in Nature - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/research-supported-by-cambridge-enterprise-and-ceres-agri-tech-published-in-nature/16 Mar 2022: Share:. New grafting technique could combat the disease threatening Cavendish bananas. ... Grafting genetically different root and shoot tissues can result in a plant with new traits – ranging from dwarf shoots, to pest and disease resistance. -
Impact Insight: Versed AI – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-versed-ai/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Versed AI. Share:. Impact Insight video case study: Versed AI. The second in our Impact Insight video series focuses on Versed AI. It tells the story behind the creation -
Research Report Commercialisation and Policy Research Authors: Dr…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/12/Roundtable-report_Commercialisation_PolicyResearch.pdf15 Dec 2022: Market-based solutions comprise many arrangements, such as licensing innovative tools, creating new companies (including social ventures), carrying out consultancies, and bringing. ... The above reduces the possibilities that usually originate from -
KARPAS 929 Human Myeloma cell line - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/karpas-929-human-myeloma-cell-line/9 May 2022: KARPAS 929 Human Myeloma cell line, developed at the University of Cambridge, useful in oncology research. -
Impact Insight video case study: iKVA – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-ikva/23 Mar 2022: Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations emerging from the University, or an external organisation looking for new -
Watch our #nextgreatidea film – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/watch-our-nextgreatidea-film/15 Feb 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Watch our #nextgreatidea film. Share:. Our film is a distinctive take on innovation that showcases some of the world-changing ideas we have supported in the journey to market – from a
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.